Sen. Elizabeth Warren, a Democrat from Massachusetts, is expressing her concerns on this big day for SpaceX, saying in a statement today that the Trump administration's Securities and Exchange ...

The SEC just made a big move on financial data. The Commission rolled out joint technical standards under the Financial Data Transparency Act of 2022, a law that’s been sitting on the shelf waiting ...

The Securities and Exchange Commission on Monday announced that it had established joint data standards as required under the Financial Data Transparency Act, and those standards aren't "as ...

Should researchers still be posting their data openly online? It’s a question being debated by some researchers now that bots are routinely mining open-access databases and scientific publications to ...

A researcher has reverse-engineered the iOS SDK that Bright Data embeds in consumer apps and documented how, with the user's consent, it can turn devices, including always-on smart TVs, into exit ...

In an exclusive interview with Meet the Press, Treasury Secretary Scott Bessent addresses concerns of a troubled economy after a disappointing jobs report raises ...

sec-edgar-mcp is sister to schwab-marketdata-mcp. Where Schwab provides prices and quotes, SEC EDGAR provides the corporate-action / disclosure backbone (10-K / 10-Q / 8-K / Form 4 insider trades, S-1 ...

Rumors and reporting circulated this week on the possibility the U.S. Securities and Exchange Commission would open a door to exempt synthetic tokenization of securities, but Commissioner Hester ...

A threat actor targeting Microsoft 365 and Azure production environments is stealing data in attacks that abuse legitimate applications and administration features. Microsoft tracks the actor as Storm ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. CB Financial Services cybersecurity disclosure reveals shadow AI risk. A harsh lesson about ...

The securities action alleges that throughout a multi-year class period, Aldeyra's leadership was aware, or recklessly disregarded, that reproxalap's clinical trial record did not support the ...

This was a new position for the fund and represented 3.64% of its reportable 13F assets under management at quarter-end. Top holdings after the filing: NYSE:U: $57.98 million (11.8% of AUM) ...